CAJ | 학술논문

胰腺癌是一种恶性度极高的肿瘤,85%的患者在就诊时已丧失手术机会,而常规化疗及放疗等治疗措施的疗效并不理想.随着分子生物学研究的进展,表皮生长因子受体抑制剂、血管内皮生长因子抑制剂等分子靶向药物的研究成为热点之一.本文就胰腺癌分子靶向治疗研究的进展做一简要综述.
이선암시일충악성도겁고적종류,85%적환자재취진시이상실수술궤회,이상규화료급방료등치료조시적료효병불이상.수착분자생물학연구적진전,표피생장인자수체억제제、혈관내피생장인자억제제등분자파향약물적연구성위열점지일.본문취이선암분자파향치료연구적진전주일간요종술.
Pancreatic cancer is one of the most malignant cancer of all neoplasm.85% cases are not suitable for surgery when at first counsultation to doctors.The effects of chemotherapy and radiotherapy are not satisfactory either.With the advancement of the study of molecular biology,the research of the molecular targeted drugs such as EGFR inhibitor and VEGF inhibitor,become one of the hot spots.This article reviews progress in the research of molecule-targeted therapy.